Acute Myeloid Leukemia (AML)

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
March, 2025
March 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
24252627282930
31  

Acute Myeloid Leukemia (AML)
Jan 15, 2025, 03:43 | Insight
Tempus AI Introduced xH: Its First Whole-Genome Sequencing Test
Tempus AI, Inc. a leader in integrating AI to enhance precision medicine and patient care,…
Nov 23, 2024, 08:18 | Blog
First Patient Treated in Phase I/II Trial in AML and ALL with Lu177-PentixaTher
Expanding the Evidence Base for Targeted Radiotherapy Approaches Pentixapharm Holding AG, a biopharmaceutical company developing…
Sep 21, 2024, 10:35 | Blog
Hung Trinh: The use of chimeric antigen receptor (CAR)-T cells has demonstrated excellent results in B-lymphoid malignancies
Hung Trinh shared a post on LinkedIn: "CAR-T cells targeting IL-1RAP produced in a closed semiautomatic…
Aug 13, 2024, 09:18 | Blog
Brittany Knick Ragon: A session on resilience and the relentless pursuit to help our patients with AML
Brittany Knick Ragon, Clinical Associate Professor at Wake Forest University School of Medicine, shared a…
Jul 4, 2024, 13:06 | Insight
Affimed Reports First Quarter 2024 Updates
As part of its Q1 reporting, Affimed revealed the first data from its LuminICE-203 AFM-13…
Jul 4, 2024, 11:35 | Blog
Peculiarities of Tumor Lysis Syndrome in Cancer Therapeutics - Chibuike Okafor
“When cancer treatment causes malignant cells to break down quickly and release their intracellular contents…
Jun 30, 2024, 09:41 | Insight
MD Anderson Cancer Center’s Research Highlights
The University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in…
May 17, 2024, 04:29 | Insight
Rasoul Pourebrahim: New potential targets for preventing AML with p53 mutations
Rasoul Pourebrahim, Assistant Professor at MD Anderson Cancer Centre, shared on LinkedIn: "Our paper was…
May 15, 2024, 10:13 | Blog
Patient dosing has commenced in the Phase 1 clinical trial of SENTI-202 - Senti Biosciences
Tim Lu, Co-Founder and CEO at Senti Biosciences, shared the following post by Senti Biosciences…
Apr 28, 2024, 13:17 | Blog
Emad Bin Zahid: Annie Im is one of the global leaders in the field of hematology-oncology
Emad Bin Zahid, Student at Tbilisi State Medical University, shared a post on LinkedIn: “Annie…
Mar 20, 2024, 15:20 | Stories
Recently we just celebrated Preston’s 1st re-birthday, his 1st anniversary of being cancer-free - The Leukemia and Lymphoma Society
The Leukemia and Lymphoma Society shared a post on LinkedIn: “ “Preston was a regular…
Feb 13, 2024, 08:00 | Blog
Talha Badar: Brief review focusing on VEN and HMA triplets in AML
Talha Badar, Hematologist/Oncologist at Mayo Clinic in Jacksonville, Florida, shared a thread on X/Twitter: "Weekend…
Jan 10, 2024, 12:30 | Insight
Hung Trinh: Researchers Develop a Potential “Universal” CAR T-Cell Therapy for Blood Cancers
Hung Trinh, Director of Process Development and MFG Science and Technology at Vyriad, posted on LinkedIn:…
Nov 16, 2023, 17:51 | Blog
Sandra Salviejo: We are excited to officially launch LLS’s first-ever documentary
Sandra Salviejo, Senior Director of Communications at The Leukemia and  Lymphoma Society (LLS), shared a…
All: 14 Posts: 1 - 100
Special Coverage